{{Chembox
| Watchedfields = changed
| verifiedrevid = 443833298
| ImageFile = Geldanamycin.svg
| ImageSize = 
| IUPACName = (4''E'',6''Z'',8''S'',9''S'',10''E'',12''S'',13''R'',14''S'',16''R'')-13-hydroxy-<wbr/>8,14,19-trimethoxy-4,10,12,16-tetramethyl<wbr/>-3,20,22-trioxo-2-azabicyclo[16.3.1]<wbr/>docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
| OtherNames = 
|Section1={{Chembox Identifiers
| Abbreviations = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 10272739
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 278315
| InChI = 1S/C29H40N2O9/c1-15-11-19-25(34)20(14-21(32)27(19)39-7)31-28(35)16(2)9-8-10-22(37-5)26(40-29(30)36)18(4)13-17(3)24(33)23(12-15)38-6/h8-10,13-15,17,22-24,26,33H,11-12H2,1-7H3,(H2,30,36)(H,31,35)/b10-8-,16-9+,18-13+/t15-,17+,22+,23+,24-,26+/m1/s1
| InChIKey = QTQAWLPCGQOSGP-KSRBKZBZBP
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C29H40N2O9/c1-15-11-19-25(34)20(14-21(32)27(19)39-7)31-28(35)16(2)9-8-10-22(37-5)26(40-29(30)36)18(4)13-17(3)24(33)23(12-15)38-6/h8-10,13-15,17,22-24,26,33H,11-12H2,1-7H3,(H2,30,36)(H,31,35)/b10-8-,16-9+,18-13+/t15-,17+,22+,23+,24-,26+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QTQAWLPCGQOSGP-KSRBKZBZSA-N
| InChIKey1 = QTQAWLPCGQOSGP-KSRBKZBZSA-N
| CASNo_Ref = {{cascite|correct|??}}
| CASNo = 30562-34-6
| EINECS = 
| PubChem = 5288382
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB02424
| SMILES = NC(=O)O[C@H]1C(/C)=C/[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)C\C2=C(/OC)C(=O)\C=C(\NC(=O)C(\C)=C\C=C/[C@@H]1OC)C2=O
| RTECS =
| MeSHName =
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI =
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = 
}}
|Section2={{Chembox Properties
| Formula = C<sub>29</sub>H<sub>40</sub>N<sub>2</sub>O<sub>9</sub>
| MolarMass = 560.64 g/mol
| Appearance = Gold-yellow fine crystalline powder
| Density = 
| MeltingPt = 
| MeltingPt_notes =
| BoilingPt = 
| BoilingPt_notes = 
| Solubility = 
| SolubleOther = 
| Solvent = 
| pKa = 
| pKb = 
| IsoelectricPt = 
| SpecRotation = 
| RefractIndex = 
| Viscosity = 
| Dipole = 
 }}
|Section3={{Chembox Structure
| CrystalStruct = 
| Coordination = 
| MolShape = 
| Dipole = 
 }}
|Section4={{Chembox Thermochemistry
| DeltaHf = 
| DeltaHc = 
| Entropy = 
| HeatCapacity = 
 }}
|Section5={{Chembox Pharmacology
| AdminRoutes =
| Bioavail = 
| Metabolism = 
| HalfLife = 
| ProteinBound =
| Excretion = 
| Legal_status =
| Legal_US =
| Legal_UK =
| Legal_AU =
| Legal_CA =
| Pregnancy_category = 
| Pregnancy_AU = 
| Pregnancy_US = 
 }}
|Section6={{Chembox Explosive
| ShockSens = 
| FrictionSens = 
| DetonationV = 
| REFactor = 
 }}
|Section7={{Chembox Hazards
| ExternalSDS = 
| EUClass = 
| MainHazards = 
| NFPA-H = 
| NFPA-F = 
| NFPA-R = 
| NFPA-S = 
| RPhrases = 
| SPhrases = 
| RSPhrases =
| FlashPt = 
| AutoignitionPt =
| ExploLimits = 
| PEL = 
 }}
|Section8={{Chembox Related
| OtherAnions = 
| OtherCations = 
| OtherFunction = 
| OtherFunction_label = 
| OtherCompounds = 
 }}
}}
'''Geldanamycin''' is a [[1,4-benzoquinone]] [[ansamycin]] [[antitumor antibiotic]] that inhibits the function of [[Hsp90]] (Heat Shock Protein 90) by binding to the unusual ADP/ATP-binding pocket of the protein.<ref>{{Cite journal 
| doi = 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2 
| last1 = Schulte | first1 = T. W. 
| last2 = Akinaga | first2 = S. 
| last3 = Soga | first3 = S. 
| last4 = Sullivan | first4 = W. 
| last5 = Stensgard | first5 = B. 
| last6 = Toft | first6 = D. 
| last7 = Neckers | first7 = L. M. 
| title = Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin 
| journal = Cell stress & chaperones 
| volume = 3 
| issue = 2 
| pages = 100–108 
| year = 1998 
| pmid = 9672245 
| pmc = 312953
}}</ref> HSP90 client proteins play important roles in the regulation of the cell cycle, cell growth, cell survival, [[apoptosis]], [[angiogenesis]] and [[oncogenesis]].

[[File:1yetgdm.png|thumb|Hsp90-geldanamycin complex. PDB {{PDBe|1yet}}<ref>{{Cite journal 
| last1 = Stebbins | first1 = C. E. 
| last2 = Russo | first2 = A. A. 
| last3 = Schneider | first3 = C. 
| last4 = Rosen | first4 = N. 
| last5 = Hartl | first5 = F. U. 
| last6 = Pavletich | first6 = N. P. 
| title = Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent 
| journal = Cell 
| volume = 89 
| issue = 2 
| pages = 239–250 
| year = 1997 
| pmid = 9108479 | doi=10.1016/S0092-8674(00)80203-2
}}</ref>]]Geldanamycin induces the degradation of proteins that are mutated in [[tumor]] cells such as [[v-Src]], [[Bcr-Abl]] and [[p53]] preferentially over their normal cellular counterparts. This effect is mediated via HSP90. Despite its potent antitumor potential, geldanamycin presents several major drawbacks as a drug candidate such as [[hepatotoxicity]], further, Jilani ''et al''. reported that geldanamycin induces the [[apoptosis]] of [[erythrocytes]] under physiological concentrations.<ref>{{Cite journal | last1 = | first1 = | last2 = | first2 = | year = 2013 | title = Geldanamycin-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane | journal = Cell Physiol Biochem | volume = 32 | issue = | pages = 1600–1609 | publisher = | jstor = | doi = 10.1159/000356596 | url = http://www.karger.com/Article/FullText/356596 | format = | accessdate = }}</ref> These side effects have led to the development of geldanamycin analogues, in particular analogues containing a derivatisation at the 17 position:

* [[17-AAG]]
* [[17-DMAG]]

== Biosynthesis ==

Geldanamycin was originally discovered in the organism ''[[Streptomyces hygroscopicus]]''.<ref>{{Cite journal 
| last1 = He | first1 = W. 
| last2 = Wu | first2 = L. 
| last3 = Gao | first3 = Q. 
| last4 = Du | first4 = Y. 
| last5 = Wang | first5 = Y. 
| title = Identification of AHBA Biosynthetic Genes Related to Geldanamycin Biosynthesis in Streptomyces hygroscopicus 17997 
| doi = 10.1007/s00284-005-0203-y 
| journal = Current Microbiology 
| volume = 52 
| issue = 3 
| pages = 197–203 
| year = 2006 
| pmid = 16502293 
| pmc = 
}}</ref> It is a macrocyclic polyketide that is synthesized by a Type I [[polyketide synthase]]. The genes gelA, gelB, and gelC encode for the polyketide synthase. The PKS is first loaded with 3-amino-5-hydroxybenzoic acid (AHBA). It then utilizes [[malonyl-CoA]], [[methylmalonyl-CoA]], and methoxymalonyl-CoA to synthesize the precursor molecule Progeldanamycin.<ref>{{Cite journal 
| last1 = Kim | first1 = W. 
| last2 = Lee | first2 = D. 
| last3 = Hong | first3 = S. S. 
| last4 = Na | first4 = Z. 
| last5 = Shin | first5 = J. C. 
| last6 = Roh | first6 = S. H. 
| last7 = Wu | first7 = C. Z. 
| last8 = Choi | first8 = O. 
| last9 = Lee | first9 = K. 
| last10 = Shen | first10 = Y. M. 
| last11 = Paik | first11 = S. G. 
| last12 = Lee | first12 = J. J. 
| last13 = Hong | first13 = Y. S. 
| title = Rational Biosynthetic Engineering for Optimization of Geldanamycin Analogues 
| doi = 10.1002/cbic.200800763 
| journal = ChemBioChem 
| volume = 10 
| issue = 7 
| pages = 1243–1251 
| year = 2009 
| pmid = 19308924 
| pmc = 
}}</ref> This precursor is subjected to several enzymatic and non-enzymatic tailoring steps to produce the active molecule Geldanamycin, which include hydroxylation, o-methylation, carbamoylation, and oxidation.<ref>{{Cite journal 
| last1 = Lee | first1 = D. 
| last2 = Lee | first2 = K. 
| last3 = Cai | first3 = X. F. 
| last4 = Dat | first4 = N. T. 
| last5 = Boovanahalli | first5 = S. K. 
| last6 = Lee | first6 = M. 
| last7 = Shin | first7 = J. C. 
| last8 = Kim | first8 = W. 
| last9 = Jeong | first9 = J. K. 
| last10 = Lee | first10 = J. S. 
| last11 = Lee | first11 = C. H. 
| last12 = Lee | first12 = J. H. 
| last13 = Hong | first13 = Y. S. 
| last14 = Lee | first14 = J. J. 
| title = Biosynthesis of the Heat-Shock Protein 90 Inhibitor Geldanamycin: New Insight into the Formation of the Benzoquinone Moiety 
| doi = 10.1002/cbic.200500441 
| journal = ChemBioChem 
| volume = 7 
| issue = 2 
| pages = 246–248 
| year = 2006 
| pmid = 16381049 
| pmc = 
}}</ref>

== Notes ==
{{reflist}}

== References ==
* {{Cite journal 
| last1 = Bedin | first1 = M. 
| last2 = Gaben | first2 = A. M. 
| last3 = Saucier | first3 = C. C. 
| last4 = Mester | first4 = J. 
| title = Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK-independent cell cycle arrest 
| doi = 10.1002/ijc.20010 
| journal = International Journal of Cancer 
| volume = 109 
| issue = 5 
| pages = 643–652 
| year = 2004 
| pmid = 14999769 
| pmc = 
}}

== External links ==
*[http://geldanamycin.info/index.htm A comprehensive  review about Geldanamycin, 17AAG and 17DMAG]
*[http://www.fermentek.co.il/geldanamycin.htm Geldanamycin from ] [[Fermentek]]
*[https://web.archive.org/web/20151122093256/http://pharmacy.mc.uky.edu/cpri/snpa.php Geldanamycin from ] [[Center for Pharmaceutical Research and Innovation]]
* [http://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=GDM Geldanamycin bound to proteins] in the [[Protein Data Bank|PDB]]

[[Category:1,4-Benzoquinones]]
[[Category:Carbamates]]
[[Category:Lactams]]
[[Category:Phenol ethers]]
[[Category:Ethers]]
[[Category:Alcohols]]
[[Category:Ansamycins]]